MARKERS FOR THE DIAGNOSIS, MONITORING AND PROGNOSIS OF OSTEOPOROSIS AND FOR ASSESSING THE RISK FOR OSTEOPOROSIS AND FOR OSTEOPOROTIC FRACTURES

摘要

Use of biomarkers in the diagnosis, monitoring and prognosis of osteoporosis and assessing the risk for osteoporosis and for osteoporotic fractures. The biomarkers include CGRP, include CGRPα and CGRPβ, and can further include a chemokine such as CXCL1, CXCL4, CXCL6 and/or CXCL8.